Chronic glycine treatment inhibits ligature-induced periodontal disease in Wistar rats

Journal of Periodontal Research

Volumn 40, Issue 1, 2005, Pages 43-47

  Breivik, Torbjørn ^a,b   Gundersen, Yngvar ^b   Fonnum, Frode ^b   Vaagenes, Per ^b   Opstad, Per Kristian ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

Author keywords

Cytokines; Glycine; Hypothalamo pituitary adrenal axis; Immune cells

Indexed keywords

CORTICOSTERONE; CYTOKINE; DRINKING WATER; GLYCINE; HORMONE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TAP WATER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTERONE BLOOD LEVEL; DISEASE COURSE; DRUG BLOOD LEVEL; EXPERIMENT; HEMOCONCENTRATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INHIBITION KINETICS; MALE; MEASUREMENT; NONHUMAN; OSTEOLYSIS; PERIODONTAL DISEASE; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; SERUM; STIMULATION; X RAY ANALYSIS;

ALVEOLAR BONE LOSS; ANIMALS; CORTICOSTERONE; DRUG EVALUATION, PRECLINICAL; GLYCINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-10; LIGATION; MALE; PERIODONTAL DISEASES; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13244279579     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00767.x     Document Type: Article

References (39)

1. Page RC. The aetiology and pathogenesis of periodontitis. Campend Contin Educ Dent 2002;23:11-14.
2. Socransky SS, Haffajee AD. The bacterial aetiology of destructive periodontal disease. J Periodont 1992;63:322-331.
3. Sela MN. Role of Treponema denticola in periodontal disease. Crit Rev Oral Biol Med 2001;12:399-413.
4. Kamma JJ, Slots J. Herpes virus-bacterial interaction in aggressive periodontitis. J Clin Periodont 2003;30:420-426.
5. Breivik T, Rook GA. Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. Clin Exp Immunol 2000;120:463-467.
6. Breivik T. Rook GA. Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. J Periodont Res 2002;37:210-214.
7. Breivik T, Rook GA. Oral treatment with SR299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. J Clin Periodont 2003;30: 931-936.
8. Tokoro Y, Matsuki Y, Yamamoto T, Suzuki T, Hara K. Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clin Exp Immunol 1997;107:166-174.
9. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
10. Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum. Porphyromonas gingivalis and Treponema denticola. J Clin Periodont 1997;24:237-248.
11. Lohinai Z, Benedek P. Feher E et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123:353-360.
12. Breivik T, Thrane PS. Psychoneuroimmune interactions in periodontal disease. In: Ader R. Felten DL, Cohen N, eds. Psychoneuroimmunlogy, 3rd edition. San Diego. CA: Academic Press, 2001:627-644.
13. Hugoson A, Ljungquist B, Breivik T. The relationship of some negative events and psychological factors to periodontal disease in an adult Swedish population 50-80 years of age. J Clin Periodont 2002;29: 247-253.
14. Ader R, Cohen N, Felten D. Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet 1995;345:99-103.
15. Breivik T, Thrane PS, Murison R, Gjermo P. Emotional stress effects on immunity, gingivitis and periodontitis. Eur J Oral Sci 1996;104:327-334.
16. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332: 1351-1361.
17. Breivik T, Opstad PK, Gjermo P, Thrane PS. Effects of hypothalamic-pituitary-adrenal axis reactivity on periodontal tissue destruction in rats. Eur J Oral Sci 2000;108:115-122.
18. Breivik T, Sluyter F, Hof M, Cools A. Differential susceptibility to periodontitis in genetically selected Wistar rat lines that differ in their behavioral and endocrinological response to stressors. Behav Genet 2000;30:123-130.
19. Breivik T, Thrane PS, Gjermo P, Opstad PK. Glucocorticoid receptor antagonist RU-486 treatment reduces periodontitis in Fischer 344 rats. J Periodont Res 2000;35:285-290.
20. Breivik T, Thrane PS, Gjermo P, Opstad PK, Pabst R, von Horsten S. Hypothalamic-pituitary-adrenal axis activation by experimental periodontal disease in rats. J Periodont Res 2001;36:295-300.
21. Breivik T, Thrane PS, Gjermo P, Fonnum F. Postnatal glutamate-induced central nervous system lesions alter periodontal disease susceptibility in adult Wistar rats. J Clin Periodont 2001;28:904-909.
22. Breivik T, Thrane PS, Gjermo P, Cools A, Myhrer T. Effects of hippocampal lesioning on experimental periodontal disease in Wistar rats. J Periodont Res 2002;37:360-365.
23. Breivik T, Stephan M, Brabant GE, Straub RH, Pabst R, von Horsten S. Postnatal lipopolysaccharide-induced illness predisposes to periodontal disease in adulthood. Brain Behav Immunol 2002;16:421-438.
24. Shoham S, Javitt DC, Heresco-Levy U. High dose glycine nutrition affects glial cell morphology in rat hippocampus and cerebellum. Int J Neuropharmacol 1999;2: 35-40.
25. Gomeza J, Ohono K. Betz H. Glycine transporter isoforms in the mammalian central nervous system: structures, functions and therapeutic promises. Curr Opin Drug Discov Devel 2003;6:675-682.
26. Wheeler MD, Ikejema K, Enomota N et al. Glycine: a new anti-inflammatory immunonutritient. Cell Mol Life Sci 1999;56:843-856.
27. Wheeler MD, Stachlewitz RF, Yamashina S, Ikejima K, Morro WAL, Thurnman RG. Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production. FASEB J 2000;14:476-484.
28. Wheeler MD, Rose ML, Ymashhima S et al. Dietary glycine blunts lung inflammatory cell influx following acute endotoxin. Am J Physiol 2000;279:390-398.
29. Li X, Bradford BU, Wheeler MD et al. Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: Role for glycine-gated chloride channels. Infect Immunol 2001;69:5883-5891.
30. Bruck R, Wardi J, Aeed H et al. Glycine modulates cytokine secretion, inhibits hepatic damage and improves survival in a model of endoxemia in mice. Liver Int 2003;23:276-282.
31. Yang S, Koo DJ, Chaudry IH, Wang P. Glycine attenuates hepatocellular depression during early sepsis and reduces sepsisinduced mortality. Crit Care Med 2001;29: 1201-1206.
32. Yamazaki K, Nakajima T, Hara K. Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease. Clin Exp Immunol 1995;99:384-391.
33. Murata Y, Yamashita A, Saito T, Sagamura K, Hamuro J. The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3 -/- and interleukin-2 receptor γ-/- mice. Int Immunol 2002;14:627-636.
34. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1-71.
35. Ziegler DR, Herman JP. Local integration of glutamate signalling in the hypothalamic paraventricular region: regulation of glucocorticoid stress responses. Endocrinology 2000;141:4801-4804.
36. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocrinol Rev 1998;19:269-301.
37. Breivik T, Gundersen Y. Osmundsen H, Opstad PK, Fonnum F. Chronic treatment with the glutamate receptor antagonist MK-801 alters periodontal disease susceptibility. J Periodont Res 2004; doi: 10.1111/j.1600-0765.2004. 00765.x
38. Skerry TM, Taylor AF. Glutamate signalling in bone. Curr Pharmacol Des 2001;7:737-750.
39. Gary C, Marie H, Arora M et al. Glutamate does not play a major role in controlling bone growth. J Bone Miner Res 2001;16:742-749.